Sec Form 3 Filing - Foat Timothy G @ Bio-Matrix Scientific Group, Inc. - 2019-10-11

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Foat Timothy G 2. Issuer Name and Ticker or Trading Symbol Bio-Matrix Scientific Group, Inc. [ BMSN] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Chief Executive Officer (Last) (First) (Middle) 1204 TANGERINE ST 3. Date of Earliest Transaction (MM/DD/YY) 10/11/2019 (Street) EL CAJON, CA92021-5011 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 12,500,000 I Trustee Sherman Family Trust Common Stock 792,500 I Trustee Bio-Technology Partners Business Trust Common Stock 3,020,143 I President Dunhill Ross Partners, Inc ( 1 ) Common Stock 437,143 I President BioScientific Consultants Common Stock 3,757 I President Sunset Cliffs Compliance Preferred Stock 1,068 I President BioScientific Consultants Preferred Stock 2,300 I Trustee Bio-Technology Partners Business Trust Preferred Stock 1,187 I President Dunhill Ross Partners ( 1 ) Preferred Series B Stock 2,678 I President BioScientific Consultants Preferred Series B Stock 179 I Trustee Bio-Technology Partners Business Trust Preferred Series B Stock 2,041 I President Dunhill Ross Partners ( 1 ) Preferred Series B Stock 75 I President Sunset Cliffs Compliance

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Foat Timothy G 1204 TANGERINE ST EL CAJON, CA92021-5011 Chief Executive Officer Signatures Timothy G Foat 12/23/2019 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Formerly Venture Bridge Advisors, Inc

Remarks: On May 23,2013 Venture Bridge Advisors, Inc (a Nevada Corporation) changes its name to Dunhill Ross Partners, Inc (A Nevada Corporation). The stock in Venture Bridge Advisors name predates this name change and has not been reissued.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.